Page last updated: 2024-08-24

fce 23884 and carbidopa

fce 23884 has been researched along with carbidopa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanchet, PJ; Chase, TN; de Jong, D; Metman, LV; Mouradian, MM	1

Trials

1 trial(s) available for fce 23884 and carbidopa

Article	Year
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Treatment Outcome	1996

Article

Year

Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3

Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Treatment Outcome

1996